Occupational and environmental hepatotoxicity

Drug-Induced Liver Disease, Second Edition

Volumn , Issue , 2007, Pages 755-769

  Tolman, Keith G ^a   Dalpiaz, Anthony S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 71149089916     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (147)

1. Hamilton A. Exploring the Dangerous Trades. Boston, NY: Little Brown, 1943:1.
2. Carson R. Silent Spring. Cambridge, MA: Riverside Press, 1962.
3. National Research Council. Toxicity Testing. Washington, DC: National Academic Press, 1984.
4. Roe D, Pearse W, Horini K, et al. Toxic Ignorance: The Continuing Absence of Basic Health Testing for Top-Selling Chemicals in the United States. New York: Environmental Defense Fund, 1997.
5. http://www.whitehouse.gov/news/releases/2002/02/20020214.html, Accessed October 24, 2005.
6. Zimmerman H. Hepatotoxicity. Adverse Effects of Drugs and Other Chemicals on the Liver. New York: Appleton-Crofts, 1978:333.
7. Pirastu R, Comba P, Reggiani A, Foa V, Masina A, Maltoni C. Mortality from liver disease among Italian vinyl chloride monomer/polyvinyl chloride manufacturers. Am J Ind Med 1990; 17(2):155-61.
8. Barberino JL, Carvalho FM, Silvany-Neto AM, et al. Liver changes in workers at an oil refinery and in a reference population in the state of Bahia Brazil. Rev Panam Salud Publica 2005; 17(1):30-7.
9. Guzelian PS. Hepatic injury due to environmental agents. Clin Lab Med 1984; 4(3):483-8.
10. Gerde P. Animal models and their limitations: on the problem of high-to-low dose extrapolations following inhalation exposures. Exp Toxicol Pathol 2005; 57(Suppl. 1):143-6.
11. Comstock GW, Edwards PQ. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. Am Rev Respir Dis 1975; 111(5):573-7.
12. Dreiff FE, Santilli N. Valproic acid hepatic fatalities: analysis of United States cases. Neurology 1986; 36(Suppl. 1):133.
13. Zimmerman HJ. Effects of aspirin and acetaminophen on the liver. Arch Intern Med 1981; 141(3):333-42.
14. Mitchell JR, Long MW, Thorgeirsson UP, Jollow DJ. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest 1975; 68(2):181-90.
15. Timbrell JA. Isoniazid metabolism in relation to hepatotoxicity. In: Davis M, Tredger JM, Williams R, eds. Drug Reactions and The Liver. Bath, UK: Pittman, 1981:190-6.
16. Spielberg SP. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed Proc 1984; 43(8):2308-13.
17. Watson RG, Olomu A, Clements D, Waring RH, Mitchell S, Elias E. A proposed mechanism for chlorpromazine jaundice-defective hepatic sulphoxidation combined with rapid hydroxylation. J Hepatol 1988; 7(1):72-8.
18. Hoft RH, Bunker JP, Goodman HI, Gregory PB. Halothane hepatitis in three pairs of closely related women. N Engl J Med 1981; 304(17):1023-4.
19. Berson A, Freneaux E, Larrey D, et al. Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J Hepatol 1994; 20(3):336-42.
20. Farrell G, Prendergast D, Murray M. Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med 1985; 313(21):1310-4.
21. Seeff LB. Drug-induced chronic liver disease, with emphasis on chronic active hepatitis. Semin Liver Dis 1981; 1(2):104-15.
22. Stock JG, Strunin L. Unexplained hepatitis following halothane. Anesthesiology 1985; 63(4):424-39.
23. Banks AT, Zimmerman HJ, Ishak KG, Harter JG. Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 1995; 22(3):820-7.
24. Ayd FJ, Jr. Chlorpromazine: ten years’ experience. JAMA 1963; 184:51-4.
25. McLean AEM. Host factors in hepatotoxicity. Isr J Med Sci 1974; 10:431.
26. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272(23):1845-50.
27. Abraham K, Geusau A, Tosun Y, Helge H, Bauer S, Brockmoller J. Severe 2,3,7,8-tetrachlorodibenzop- dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction. Clin Pharmacol Ther 2002; 72(2):163-74.
28. Daniels N. Chevron v Echazabal: protection, opportunity, and paternalism. Am J Public Health 2003; 93(4):545-8.
29. Fernandez-D’Pool J, Orono-Osorio A. Liver function of workers occupationally exposed to mixed organic solvents in a petrochemical industry. Invest Clin 2001; 42(2):87-106.
30. Rehwagen M, Krumbiegel P, Koschny I, Rolle-Kampczyk U, Richter M, Herbarth O. The [15N]methacetin liver function test characterizes multicomponent exposure of children in industrially polluted regions. Isotopes Environ Health Stud 2001; 37(2):167-74.
31. Knasmuller S, Cavin C, Chakraborty A, et al. Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: implications for risk assessment. Nutr Cancer 2004; 50(2):190-7.
32. Knasmuller S, Mersch-Sundermann V, Kevekordes S, et al. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 2004; 198(1-3):315-28.
33. Fastner J, Heinze R, Humpage AR, Mischke U, Eaglesham GK, Chorus I. Cylindrospermopsin occurrence in two German lakes and preliminary assessment of toxicity and toxin production of Cylindrospermopsis raciborskii (Cyanobacteria) isolates. Toxicon 2003; 42(3):313-21.
34. Pollet C, Bar F, Battista S, et al. Identification and evaluation of liver damage in subjects exposed to occupational risk from general anesthetics. Med Lav 2003; 94(5):421-31.
35. Creech JL, Jr., Johnson MN. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J Occup Med 1974; 16(3):150-1.
36. Recknagel RO, Glende EA, Jr., Dolak JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 1989; 43(1):139-54.
37. Zimmerman HJ. Effects of alcohol on other hepatotoxins. Alcohol Clin Exp Res 1986; 10(1):3-15.
38. Poland A, Kende A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin: environmental contaminant and molecular probe. Fed Proc 1976; 35(12):2404-11.
39. Dianzani M. Biochemical aspects of fatty liver. In: Meeks RG, Harrison SD, Bull RJ, eds. Hepatotoxicity. Boca Raton, FL: CRC Press, 1991:327.
40. Bolt HM. Vinyl chloride-a classical industrial toxicant of new interest. Crit Rev Toxicol 2005; 35(4):307-23.
41. NIOSH. Pocket Guide to Chemical Hazards. U.S. Government Printing Office, ed. U.S. Department of Health and Human Services Publications 94-116. U.S. Government Printing Office, 1994.
42. Strauss N. Hepatotoxic effects following occupational exposure to halowax (chlorinated hydrocarbons). Rev Gastroenterol 1994; 11:381.
43. D’Itri FM, Kamrin MA, eds. PCBs: Human and Environmental Hazards. Woburn, MA: Butterworths, 1983.
44. Peakall DB, Lincer JL. Poly chlorinated biphenyls: another long-life, widespread chemical in the environment. Bioscience 1970; 20:958.
45. Kimbrough RD. Human health effects of polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs). Annu Rev Pharmacol Toxicol 1987; 27:87-111.
46. Fries GF. The PBB episode in Michigan: an overall appraisal. Crit Rev Toxicol 1985; 16(2):105-56.
47. LaDou J. The export of environmental responsibility. Arch Environ Health 1994; 49(1):6-8.
48. Kimbrough RD. The toxicity of polychlorinated polycyclic compounds and related chemicals. CRC Crit Rev Toxicol 1974; 2(4):445-98.
49. Goldstein JA, Friesen M, Scotti TM, Hickman P, Hass JR, Bergman H. Assessment of the contribution of chlorinated dibenzo-p-dioxins and dibenzofurans to hexachlorobenzene-induced toxicity, porphyria, changes in mixed function oxygenases, and histopathological changes. Toxicol Appl Pharmacol 1978; 46(3):633-49.
50. Kuratsune M, Yoshimura T, Matzuzaka J, Yamaguchi A. Epidemiologic study on Yusho, a poisoning caused by ingestion of rice oil contaminated with a commercial brand of polychlorinated biphenyls. Environ Health Perspect 1972; 1:119-28.
51. Fouts JR. Interactions of chemicals and drugs to produce effects on organ function. In: Lee DHK, Koten P, eds. Multiple Factors in the Causation of Environmentally Induced Disease. New York:Academic Press, 1972:109-18.
52. Mitchell JR, Gillette JR. Drug-chemical interactions as a factor in environmentally induced disease. In: Lee DHK, Koten P, eds. Multiple Factors in the Causation of Environmentally Induced Disease. New York: Academic Press, 1972:119-31.
53. Poland A, Knutson JC. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 1982; 22:517-54.
54. Hardin BL, Jr. Carbon tetrachloride poisoning; a review. Ind Med Surg 1954; 23(3):93-105.
55. Jennings RB. Fatal fulminant acute carbon tetrachloride poisoning. AMA Arch Pathol 1955; 59(3):269-84.
56. Von Oettingen WF. The Halogenated Hydrocarbons of Industrial and Toxicological Importance. Amsterdam: Elsevier, 1964.
57. Recknagel RO, Glende EA, Jr. Carbon tetrachloride hepatotoxicity: an example of lethal cleavage. CRC Crit Rev Toxicol 1973; 2:263-97.
58. Reichert D. Biological actions and interactions of tetrachloroethylene. Mutat Res 1983; 123(3):411-29.
59. Reuber MD, Glover EL. Cirrhosis and carcinoma of the liver in male rats given subcutaneous carbon tetrachloride. J Natl Cancer Inst 1970; 44(2):419-27.
60. Drill VA. Hepatotoxic agents; mechanism of action and dietary interrelationship. Pharmacol Rev 1952; 4(1):1-42.
61. Rouiller CH. Experimental toxic injury of the liver. In: Rouiller CH, ed. The Liver, Vol. II. New York:Academic Press, 1964:335-476.
62. Schoental R. Liver disease and “natural” hepatotoxins. Bull World Health Organ 1963; 29:823-33.
63. Gurney R. Tetrachloroethane intoxication. Early recognition of liver damage and means of prevention. Gastroenterology 1943; 1:1112.
64. Jeney E, Bartha F, Kondor L, Szendrei S. Prevention of industrial tetrachloroethane intoxication. Part 3. Egeszegtudmany 1967; 1:155-64.
65. Horiuchi K, Moriguchi S, Monimoto K, et al. Studies on industrial tetrachloroethane poisoning. Osaka City Med J 1962; 8:29-38.
66. WHO. Environmental Health Criteria 139. Partially Halogenated Chlorofluorocarbons (Ethane Derivatives). Geneva: WHO, 1992.
67. Hoet P, Graf ML, Bourdi M, et al. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons. Lancet 1997; 350(9077):556-9.
68. Harris JW, Jones JP, Martin JL, et al. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation. Chem Res Toxicol 1992; 5(5):720-5.
69. Malley LA, Carakostas M, Hansen JF, Rusch GM, Kelly DP, Trochimowicz HJ. Two-year inhalation toxicity study in rats with hydrochlorofluorocarbon 123. Fundam Appl Toxicol 1995; 25(1):101-14.
70. Urban G, Speerschneider P, Dekant W. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1. Chem Res Toxicol 1994; 7(2):170-6.
71. Malley LA, Carakostas M, Elliott GS, et al. Subchronic toxicity and teratogenicity of 2-chloro-1,1,1,2- tetrafluoroethane (HCFC-124). Fundam Appl Toxicol 1996; 32(1):11-22.
72. Marit GB, Dodd DE, George ME, Vinegar A. Hepatotoxicity in guinea pigs following acute inhalation exposure to 1,1-dichloro-2,2,2-trifluoroethane. Toxicol Pathol 1994; 22(4):404-14.
73. Lind RC, Gandolfi AJ, Hall PD. Biotransformation and hepatotoxicity of HCFC-123 in the guinea pig:potentiation of hepatic injury by prior glutathione depletion. Toxicol Appl Pharmacol 1995; 134(1):175-81.
74. Dekant W. Toxicology of chlorofluorocarbon replacements. Environ Health Perspect 1996; 104(Suppl. 1):75-83.
75. Lukaszewski T. Acute tetrachloroethylene fatality. Clin Toxicol 1979; 15(4):411-5.
76. Hake CL, Stewart RD. Human exposure to tetrachloroethylene: inhalation and skin contact. Environ Health Perspect 1977; 21:231-8.
77. Meckler LC, Phelps DK. Liver disease secondary to tetrachloroethylene exposure. A case report. JAMA 1966; 197(8):662-3.
78. Stewart RD. Actue tetrachloroethylene intoxication. JAMA 1969; 208(8):1490-2.
79. Stewart RD, Gay HH, Erley DS, et al. Human exposure to tetrachloroethylene vapor. Arch Environ Health 1961; 2:516-22.
80. National Cancer Institute. Bioassay of Tetrachloroethylene for Possible Carcinogenicity. NCI TR 13. DHEW (NIH) Pub No. 77-813: NTIS Pub No PB-272-940. Springfield, VA: National Technical Service.
81. Thomas LB, Popper H, Berk PD, Selikoff I, Falk H. Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti’s syndrome) to Angiosarcomas. N Engl J Med 1975; 292(1):17-22.
82. Li Y, Zhou M, Marion MJ, Lee S, Brandt-Rauf PW. Polymorphisms in glutathione S-transferases in French vinyl chloride workers. Biomarkers 2005; 10(1):72-9.
83. Johnson MD. Letter from Medical Director of Chemstrand Corportation to the TLV Committee, March 1961.
84. Corsi GC. On occupational pathology caused by dimethylacetmide (with special reference to hepatic function). Med Lav 1971; 62(1):28-42.
85. Spies GJ, Rhyne RH, Jr., Evans RA, et al. Monitoring acrylic fiber workers for liver toxicity and exposure to dimethylacetamide. 1. Assessing exposure to dimethylacetamide by air and biological monitoring. J Occup Environ Med 1995; 37(9):1093-101.
86. Kelly DP. Subchronic inhalation toxicity of dimethyl acetamide in rats. Toxicologist 1984; 4:65.
87. Horn HJ. Toxicology of dimethylacetamide. Toxicol Appl Pharmacol 1961; 3:12-24.
88. Clayton JW, Jr., Barnes JR, Hood DB, Schepers GW. The inhalation toxicity of dimethylformamide (DMF). Am Ind Hyg Assoc J 1963; 24:144-54.
89. Craig DK, Weir RJ, Wagner W, Groth D. Subchronic inhalation toxicity of dimethylformamide in rats and mice. Drug Chem Toxicol 1984; 7(6):551-71.
90. Lundberg I, Lundberg S, Kronevi T. Some observations on dimethylformamide hepatotoxicity. Toxicology 1981; 22(1):1-7.
91. Wiles JS, Narcisse JK, Jr. The acute toxicity of dimethylamides in several animal species. Am Ind Hyg Assoc J. 1971; 32(8):539-45.
92. Kennedy GL, Jr., Sherman H. Acute and subchronic toxicity of dimethylformamide and dimethylacetamide following various routes of administration. Drug Chem Toxicol 1986; 9(2):147-70.
93. Kennedy GL, Jr. Biological effects of acetamide, formamide, and their monomethyl and dimethyl derivatives. Crit Rev Toxicol 1986; 17(2):129-82.
94. Massman W. Toxicological investigations on dimethylformamide. Br J Ind Med 1956; 13:51-4.
95. Wang JD, Lai MY, Chen JS, et al. Dimethylformamide-induced liver damage among synthetic leather workers. Arch Environ Health 1991; 46(3):161-6.
96. Potter HP. Dimethylformamide-induced abdominal pain and liver injury. Arch Environ Health 1973; 27(5):340-1.
97. Buylaert W, Calle P, De Paepe P, et al. Hepatotoxicity of N, N-dimethylformamide (DMF) in acute poisoning with the veterinary euthanasia drug T-61. Hum Exp Toxicol 1996; 15(8):607-11.
98. Poelmans L, van Besien B, Van Ganse W, Deprez A. Toxic hepatitis due to dimethylformamide: case reports and literature review. Acta Clin Belg 1996; 51(5):360-6.
99. Redlich CA, West AB, Fleming L, True LD, Cullen MR, Riely CA. Clinical and pathological characteristics of hepatotoxicity associated with occupational exposure to dimethylformamide. Gastroenterology 1990; 99(3):748-57.
100. Vettorazzi G. Toxicological decisions and recommendations resulting from the safety assessment of pesticide residues in food. CRC Crit Rev Toxicol 1975; 4(2):125-83.
101. Von Oettingen WF. The Halogenated Aliphatic, Olephinic, Cyclic, Aromatic and Aliphatic-Aromatic Hydrocarbons Including the Halogenated Insecticides: Their Toxicity and Potential Dangers U.S. Department H.E.W. Washington, DC: U.S. Government Printing Office, 1995.
102. Beloskurshaya GI, Korolchuk EI. Time course of the liver aspect enzymogram in workers engaged in phosphorus production and in patients with chronic phosphorus poisoning after hypobaric oxygenation. Gigiens Trunda I Professionalye Zabolevani. July 11, 1984.
103. Smith NJ. Death following accidental ingestion of DDT. JAMA 1948; 136:469-71.
104. Morgan DP, Roan CC. Liver function in workers having high tissue stores of chlorinated hydrocarbon pesticides. Arch Environ Health 1974; 29(1):14-7.
105. Tomatis L. The IARC program on the evaluation of the carcinogenic risk of chemicals to man. Ann NY Acad Sci 1976; 271:396-409.
106. Timbrell JA, Scales MD, Streeter AJ. Studies on hydrazine hepatotoxicity. 2. Biochemical findings. J Toxicol Environ Health 1982; 10(6):955-68.
107. Weisberger EK. Halogenated substances: environmental and industrial materials. In: Khan MAQ, Stanton RH, eds. Toxicology of Halogenated Hydrocarbons: Health and Ecological Effects, Vol. 3. New York: Pergamon Press, 1981:22.
108. Ecobichon DJ. Toxic effects of pesticides. In: Klaassen CD, ed. Cassarettand Doull’s Toxicology: The Basic Science of Poisons. 5th ed. New York: McGraw-Hill, 1996:643-90.
109. Wade N. Viets and vets fear herbicide health effects. Science 1979; 204(4395):817.
110. Sterling TD, Arundel A. Review of recent Vietnamese studies on the carcinogenic and teratogenic effects of phenoxy herbicide exposure. Int J Health Serv 1986; 16(2):265-78.
111. Council on Scientific Affiars of the AMA. The Health Effects of “Agent Orange” and Poly-chlorinated Dioxin Contaminants. Chicago, IL: American Medical Association, 1981.
112. Jirasek L, Kalensky J, Kubec K, Pazderova J, Lukas E. Chloracne, porphyria cutanea tarda, and other poisonings due to the herbicides. Hautarzt 1976; 27(7):328-33.
113. Pazderova-Vejlupkova J, Lukas E, Nemcova M, Pickova J, Jirasek L. The development and prognosis of chronic intoxication by tetrachlordibenzo-p-dioxin in men. Arch Environ Health 1981; 36(1):5-11.
114. Guzelian PS. Comparative toxicology of chlordecone (Kepone) in humans and experimental animals. Annu Rev Pharmacol Toxicol 1982; 22:89-113.
115. Blanke RV, Fariss MW, Griffith FD, Jr., Guzelain PS. Analysis of chlordecone (Kepone) in biological specimens. J Anal Toxicol 1977; 1:57.
116. Huggett RJ, Bender ME. Kepone in the James River. Environ Sci Technol 1980; 14:918-23.
117. Huggett RJ, Nichols MM, Bender ME. Kepone contamination of the James River Estuary. Contam Sediments 1980; 1:33.
118. Sterrett FS, Boss CA. Careless Kepone. Environment 1977; 19:30.
119. The Kepone catastrophe. Washington Post, December 21, 1975.
120. Larson PS, Egle JL, Jr., Hennigar GR, Lane RW, Borzelleca JF. Acute, subchronic, and chronic toxicity of chlordecone. Toxicol Appl Pharmacol 1979; 48(1 Pt 1):29-41.
121. Bullivant CM. Accidental poisoning by paraquat: report of two cases in man. Br Med J 1966; 5498:1272-3.
122. Carson DJ, Carson ED. The increasing use of paraquat as a suicidal agent. Forensic Sci 1976; 7(2):151-60.
123. Bus JS, Aust SD, Gibson JE. Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity. Biochem Biophys Res Commun 1974; 58(3):749-55.
124. Mullick F G, Ishak KG, Mahabir R, Stromeyer FW. Hepatic injury associated with paraquat toxicity in humans. Liver 1981; 1(3):209-21.
125. Wogan GN. Mycotoxins and liver injury. In: Gall EA, Mostofi FK, eds. The Liver. Baltimore, MD:Williams & Wilkins, 1973:161-81.
126. Swarbock O. Disease of turkey poults. Vet Rec 1960; 72:671.
127. Smith KM. Disease of turkey poults. Vet Rec 1960; 72:652.
128. Goldblatt LA, ed. Aflatoxin: Scientific Background: Control and Implications. New York: Academic Press, 1969.
129. Newberne PM. Chemical carcinogenesis: mycotoxins and other chemicals to which humans are exposed. Semin Liver Dis 1984; 4(2):122-35.
130. Butler WH. Liver injury induced by aflatoxin. Prog Liver Dis 1970; 3:408-18.
131. Newberne PM, Butler WH. Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. Cancer Res 1969; 29(1):236-50.
132. Alpert E, Serck-Hanssen A, Rajagopolan B. Aflatoxin-induced hepatic injury in the African monkey. Arch Environ Health 1970; 20(6):723-8.
133. Anonymous. IRAC Monograph on the Evaluation of Carcinogenic Risks of Humans. Vol. 56. Lyon, France: International Agency for Research on Cancer, 1993.
134. Wogan GN. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 1992; 52(Suppl. 7):2114s-8s.
135. Montesaano R, Kirby GM. Chemical carcinogenesis in human liver cancer. In: Brechot C, ed. Primary Liver Cancer: Etiological and Progression Factor. Boca Raton, FL: CRC Press, 1994:57-77.
136. Wogan GN, Edwards GS, Newberne PM. Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. Cancer Res 1971; 31(12):1936-42.
137. Pong RS, Wogan GN. Time course and dose-response characteristics of aflatoxin B1 effects on rat liver RNA polymerase and ultrastructure. Cancer Res 1970; 30(2):294-304.
138. Eaton DL, Gallagher EP. Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 1994; 34:135-72.
139. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350(6317):427-8.
140. Fletcher GF, Galambos JT. Phosphorus poisoning in humans. Arch Intern Med 1963; 112:846-52.
141. Diaz-Rivera RS, Collazo PJ, Pons ER, Torregrosa MV. Acute phosphorus poisoning in man: a study of 56 cases. Medicine (Baltimore) 1950; 29(4):269-98.
142. Rodriguez-Iturbe B. Acute yellow-phosphorus poisoning. N Engl J Med 1971; 284(3):157.
143. McCarron MM, Gaddis GP, Trotter AT. Acute yellow phosphorus poisoning from pesticide pastes. Clin Toxicol 1981; 18(6):693-711.
144. LaDue JS, Schenken JR, Kuker LH. Phosphorus poisoning. A report of sixteen cases with repeated liver biopsies in a recovered case. Am J Med Sci 1944; 208:223.
145. Cotrim HP, Freitas LA, Parana R, et al. Non alcoholic steatohepatitis (NASH) and environmental toxins: a liver disease in workers from an industrial area. Hepatology 1996; 24:337 (abstract).
146. Cotrim HP, Parana R, Portugal M, et al. Non-alcoholic steatohepatitis (NASH) and industrial toxins:follow up of patients removed from one industrial area. Hepatology 1997; 26:149 (abstract).
147. Tolman KG, Sirrine R. Industrial hepatotoxicity. Clin Liver Dis 1998; 2(3):563-89.